Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.
Thel, M C
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. [electronic resource] - The American journal of cardiology Feb 2000 - 427-34 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0002-9149
10.1016/s0002-9149(99)00767-5 doi
Aged
Angina, Unstable--mortality
Angioplasty, Balloon, Coronary--adverse effects
Coronary Thrombosis--mortality
Electrocardiography
Eptifibatide
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Myocardial Infarction--etiology
Peptides--administration & dosage
Platelet Aggregation Inhibitors--administration & dosage
Prospective Studies
Risk Factors
Secondary Prevention
Survival Rate
Thrombolytic Therapy
Time Factors
Treatment Outcome
United States--epidemiology
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. [electronic resource] - The American journal of cardiology Feb 2000 - 427-34 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0002-9149
10.1016/s0002-9149(99)00767-5 doi
Aged
Angina, Unstable--mortality
Angioplasty, Balloon, Coronary--adverse effects
Coronary Thrombosis--mortality
Electrocardiography
Eptifibatide
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Myocardial Infarction--etiology
Peptides--administration & dosage
Platelet Aggregation Inhibitors--administration & dosage
Prospective Studies
Risk Factors
Secondary Prevention
Survival Rate
Thrombolytic Therapy
Time Factors
Treatment Outcome
United States--epidemiology